Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection

Virology

Volumn 239, Issue 1, 1997, Pages 36-45

  Neubauer, Antonie ^a   Beer, Martin ^a   Brandmüller, Christine ^a   Kaaden, Oskar Rüger ^a   Osterrieder, Nikolaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EQUINE HERPES VIRUS; IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN LYMPHOCYTE; VIRUS INFECTION; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ANIMALIA; DNA VIRUSES; EQUIDAE; EQUINE HERPESVIRUS 1; ESCHERICHIA COLI; HERPES; HERPESVIRIDAE; HERPESVIRUS 1; MURINAE;

EID: 0031455515     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8857     Document Type: Article

References (40)

1. Allen G. P., Bryans J. T. Molecular epizootology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Progresses in Veterinary Microbiology and Immunology. 1986;Karger, Basel. p. 78-144.
2. Allen G. P., Yeargan M. R. Use of λgt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J. Virol. 61:1987;2454-2461.
3. Allen G. P., Yeargan M., Costa L. R. R., Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 69:1995;606-612.
4. Awan A. R., Chong Y.-C., Field H. J. The pathogenesis of equine herpesvirus type 1 in the mouse: A new model for studying host responses to the infection. J. Gen. Virol. 71:1990;1131-1140.
5. Colle C. F., Tarbet E. B., Grafton W. D., Jennings S. R., O'Callaghan D. J. EHV-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain, RacL. Virus Res. 43:1996;111-124.
6. Cornick J., Martens J., Martens R., Crandell R., McConnell S., Kit S. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses. Can. J. Vet. Res. 54:1990;206-260.
7. Da Costa X. J., Bourne N., Stanberry L. R., Knipe D. M. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Virology. 232:1997;1-12.
8. Farrell H. E., McLean C. S., Efstathiou S., Inglis, Minson A. C. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J. Virol. 68:1994;927-932.
9. Heffner S., Kovacs F., Klupp B. G., Mettenleiter T. C. Glycoprotein gp50-negative pseudorabies virus: A novel approach toward a nonspreading live herpesvirus vaccine. J. Virol. 67:1993;1529-1537.
10. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6:1979;65-70.
11. Hübert P. H., Birkenmaier S., Rziha H. J., Osterrieder N. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. J. Vet. Med. B. 43:1996;1-14.
12. Kyhse-Andersen J. Electroblotting of multiple gels: A simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J. Biochem. Biophys. Methods. 10:1984;203-214.
13. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
14. MacLean C. A., Robertson L. M., Jamieson F. E. Characterization of the UL10 gene product of herpes simplex virus type 1 and investigation of its role in vivo. J. Gen. Virol. 74:1993;975-983.
15. Marshall K. R., Sun Y., Brown M. S., Field H. J. An equine herpesvirus-1 gene 71 deletant is attenuated and elicits a protective immune response in mice. Virology. 231:1997;20-27.
16. Matsumura T., O'Callaghan D. J., Kondo T., Kamada M. Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. Vet. Microbiol. 48:1996;353-365.
17. Mayr A., Pette J., Petzoldt K., Wagener K. Untersuchungen zur Entwicklung eines Lebendimpfstoffes gegen die Rhinopneumonitis (Stutenabort) der Pferde. J. Vet. Med. B. 15:1968;406-418.
18. McLean C. S., Erturk M., Jennings R., NiChallanain D., Minson A. C., Duncan I., Boursnell M. E. G., Inglis S. Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J. Infect. Dis. 170:1994;1100-1109.
19. Mettenleiter T. C., Rauh I. A glycoprotein gX-β-galactosidase fusion gene as insertional marker for rapid identification of pseudorabies virus mutants. J. Virol. Methods. 30:1990;55-66.
20. Mettenleiter T. C., Klupp B. G., Weiland F., Visser N. Characterization of a quadruple-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. J. Gen. Virol. 75:1994;1723-1733.
21. Morrison L. A., Knipe D. M. Immunization with replication-defective mutants of herpes simplex virus type 1: Sites of immune intervention in pathogenesis of challenge virus infection. J. Virol. 68:1994;689-696.
22. Morrison L. A., Knipe D. M. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology. 220:1996;402-413.
23. Muir D., Varon S., Manthorpe M. An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures. Anal. Biochem. 185:1990;377-382.
24. J. A. Mumford, D. A. Hannant, D. M. Jessett, T. O'Neill, K. C. Smith, E. N. Ostlund, 1995, Abortigenic and neurological disease caused by experimental infection with equid herpesvirus-1, Proceedings 7th International Conference of Equine Infectious Diseases, 261, 275, R&W Publ. Newmarket, U.K. United Kingdom.
25. Neubauer A., Braun B., Brandmüller C., Kaaden O.-R., Osterrieder N. Analysis of the contributions of the equine herpesvirus 1 (EHV-1) glycoprotein gB-homolog to virus entry and direct cell-to-cell spread. Virology. 227:1997;281-294.
26. Nguyen L. H., Knipe D. M., Finberg R. W. Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection. J. Virol. 66:1992;7067-7072.
27. Osterrieder N., Wagner R., Brandmüller C., Schmidt P., Wolf H., Kaaden O.-R. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology. 208:1995;500-510.
28. Osterrieder N., Neubauer A., Brandmüller C., Braun B., Kaaden O.-R., Baines J. D. The equine herpesvirus type 1 glycoprotein gp21/22a, the herpes simplex virus type 1 gM-homolog, is involved in virus penetration and cell-to-cell spread of virions. J. Virol. 70:1996a;4110-4115.
29. Osterrieder N., Neubauer A., Brandmüller C., Kaaden O.-R., O'Callaghan D. J. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperatures and is a major determinant of virulence. Virology. 226:1996b;243-251.
30. Osterrieder N., Neubauer A., Fakler B., Brandmüller C., Seyboldt C., Kaaden O.-R., Baines J. D. Synthesis and processing of the equine herpesvirus 1 glycoprotein M. Virology. 232:1997;230-239.
31. Peeters B., Bouma A., De Bruin T., Moormann R., Gielkens A., Kimman T. Non-transmissible pseudorabies virus gp50 mutants: A new generation of safe live vaccines. Vaccine. 12:1994;375-380.
32. Pilling A., Davison A. J., Telford E. A. R., Meredith D. M. The equine herpesvirus type 1 glycoprotein homologous to herpes simplex virus type 1 glycoprotein M is a major constituent of the virus particle. J. Gen. Virol. 75:1994;439-442.
33. Sambrook J., Fritsch D. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
34. Slater J. D., Gibson J. S., Field H. J. Pathogenicity of thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. J. Gen. Virol. 74:1993;819-828.
35. Stokes A., Alber D. G., Greensill J., Amellal B., Carvalho R., Taylor L. A., Doel T. R., Killington R. A., Halliburton I. W., Meredith D. M. The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res. 40:1996;91-107.
36. Sullivan D. C., Allen G. P., O'Callaghan D. J. Synthesis and processing of equine herpesvirus type 1 glycoprotein 14. Virology. 173:1989;638-646.
37. Telford E. A. R., Watson M. S., McBride K., Davison A. J. The DNA sequence of equine herpesvirus-1. Virology. 189:1992;304-316.
38. Tewari D., Whalley J. M., Love D. N., Field H. J. Characterisation of immune responses to baculovirus expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75:1994;1735-1741.
39. vanWoensel P. A. M., Goovaerts D., Marx D., Visser N. A mouse model for testing the pathogenicity of equine herpes virus-1 strains. J. Virol. Methods. 54:1995;39-49.
40. Wemme H., Pfeifer S., Heck R., Müller-Quernheim J. Measurement of lymphocyte proliferation: Critical analysis of radioactive and photometric methods. Immunobiology. 185:1992;78-89.